Close
Show

Press Releases

Press Releases is unique and effective promotional tool offered from Worldpharmatoday.com aimed at bringing our client’s business message into limelight and more importantly make it reach their target audience. This feature can be utilized to launch new product, promoting existing Pharma product, publish business agreements, annual reports, financial results, corporate performances, important announcements or any important information that has to be conveyed to the target audience.

U.S. Food and Drug Administration Approves Humalog® 200 units/mL KwikPen®


The U.S. FDA has approved Humalog® 200 units/mL KwikPen, a pre-filled pen containing a concentrated...

Lilly Sends Employees to Serve in Vulnerable Communities around the World


First Connecting Hearts Abroad volunteers leave this month to help people in need in Thailand,...

Bristol-Myers Squibb Announces the Expiration of its Cash Tender Offer


NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced the expiration, as of 11:59 p.m., New York...

Bristol-Myers Squibb Receives Positive CHMP Opinion in the European Union for Nivolumab (Opdivo, Nivolumab...


Nivolumab is the first PD-1 immune checkpoint inhibitor to receive a positive opinion from the...

Bristol-Myers Squibb Receives Amended U.S. FDA Breakthrough Therapy Designation for Investigational Daclatasvir-based Hepatitis C...


Breakthrough Designation for daclatasvir and sofosbuvir combination is supported by the recently presented ALLY-1 trial...

Eric Stonestreet, of Television’s Hit Comedy, “Modern Family” Joins Forces with Bristol-Myers Squibb to...


• Ready. Raise. Rise. encourages everyone touched by cancer to create a personalized, virtual flag...

Lilly and Sanford-Burnham Announce Collaboration to Investigate Immunological Therapies


INDIANAPOLIS, May 14, 2015 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Sanford-Burnham Medical...

Bristol-Myers Squibb to Present Data at 2015 American Society of Clinical Oncology (ASCO) Annual...


Pivotal Phase III studies (CheckMate -057 & -017) in both advanced non-squamous and squamous non-small...

Bristol-Myers Squibb Announces the Early Results of its Cash Tender Offer For Up to...


NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that, pursuant to its previously announced cash...

Bristol-Myers Squibb Announces the Pricing Terms of its Cash Tender Offer For Up to...


NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today the pricing terms of its previously announced...